Trial Profile
Safety and pharmacokinetics of Dabigatran in subjects with Atrial Fibrillation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thromboembolism
- Focus Adverse reactions; Pharmacokinetics
- 11 May 2016 New trial record